Alexander G. Semenov, PhD, a project manager in R&D department of Finnish biotech company HyTest - a producer of monoclonal antibodies and antigens for the diagnostic industry and research communities.
Alexander G. Semenov graduated from Moscow State University majored in biochemistry and received PhD in biochemistry from the same university. Since 2005 he has been involved in research projects of HyTest focused on B-type natriuretic peptide (BNP) and BNP-related peptides. The results of these studies were presented at high-level conferences and published in high impact international journals (e.g. Clinical Chemistry, Clinical Biochemistry).